Active substance
Fenoprofen
- US FDA 35
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FENOPROFEN CALCIUM | EQ 400MG BASE; EQ 200MG BASE; EQ 300MG BASE | capsule · oral | RISING | Prescription | 18 Jul 2022 |
| FENOPROFEN CALCIUM | EQ 200MG BASE; EQ 300MG BASE | capsule · oral | MISEMER | Prescription | 16 May 2023 |
| NALFON | EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 200MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule · oral | PHARMACO | Discontinued | 16 Mar 1976 |
| NALFON | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | DISTA | Discontinued | 9 Jun 1977 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | DAVA PHARMS INC | Discontinued | 20 Apr 1988 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | ANI PHARMS | Discontinued | 2 May 1988 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | PHARMACO | Discontinued | 8 Jun 1988 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | WATSON LABS TEVA | Discontinued | 13 Jun 1988 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | STRIDES PHARMA INTL | Discontinued | 19 Jul 1988 |
| FENOPROFEN CALCIUM | EQ 200MG BASE | capsule · oral | PAR PHARM | Discontinued | 22 Aug 1988 |
| FENOPROFEN CALCIUM | EQ 300MG BASE | capsule · oral | PAR PHARM | Discontinued | 22 Aug 1988 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | 29 Aug 1988 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | WATSON LABS | Discontinued | 11 Oct 1988 |
| FENOPROFEN CALCIUM | EQ 300MG BASE | capsule · oral | RISING | Discontinued | 14 Oct 1988 |
| FENOPROFEN CALCIUM | EQ 200MG BASE | capsule · oral | RISING | Discontinued | 17 Oct 1988 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | RISING | Discontinued | 17 Oct 1988 |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 21 Dec 1990 |
| FENOPROFEN CALCIUM | EQ 200MG BASE | capsule · oral | WATSON LABS | Discontinued | 19 Aug 1991 |
| FENOPROFEN CALCIUM | EQ 300MG BASE | capsule · oral | WATSON LABS | Discontinued | 19 Aug 1991 |
| FENOPROFEN CALCIUM | EQ 400MG BASE | capsule · oral | MISEMER | Discontinued | 16 May 2023 |
| FENOPROFEN CALCIUM | EQ 300MG BASE | capsule · oral | QUANTUM PHARMICS | Discontinued | |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | WATSON LABS | Discontinued | |
| FENOPROFEN CALCIUM | EQ 600MG BASE | tablet · oral | QUANTUM PHARMICS | Discontinued | |
| FENOPROFEN CALCIUM | EQ 200MG BASE | capsule · oral | QUANTUM PHARMICS | Discontinued | |
| FENOPROFEN CALCIUM | EQ 300MG BASE | capsule · oral | WATSON LABS | Discontinued |
10 more — full table
Safety signals and safety-related labeling changes
- US FDA 21 Nov 2024 NALFON — safety-related labeling change
Labeling sections changed: Boxed Warning; Warnings and Precautions; Adverse Reactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.